01.06 2012 . 6-

7- (Regeneron), 2012 R&D 625 . . . 6- (Vertex), 2012 R&D 806 . . . 14% , 2011 (707 . . ), 62% . 16,4 . .

, (Food and Drug Administration, FDA) . , , , R&D- , , , .